Tvardi Therapeutics, Inc. (TVRD) › Operating IncomeTvardi Therapeutics, Inc. (TVRD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: -$6.24M2013: -$237.0K2014: -$18.07M2015: -$25.19M2016: -$58.40M2017: -$59.48M2018: -$77.38M2019: -$111.68M2020: $5.38M2021: -$89.08M2022: -$87.53M2023: -$121.50M2024: -$28.11M2025: -$26.75M-$26.75M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$26.75M+4.8%2024-$28.11M+76.9%2023-$121.50M-38.8%2022-$87.53M+1.7%2021-$89.08M-1754.3%2020$5.38M+104.8%2019-$111.68M-44.3%2018-$77.38M-30.1%2017-$59.48M-1.9%2016-$58.40M-131.9%2015-$25.19M-39.4%2014-$18.07M-7525.3%2013-$237.0K+96.2%2012-$6.24M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share